These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23548421)

  • 1. [Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].
    Tepliakov AT; Shilov SN; Berezikova EN; Efremov AV; Safronov ID; Pustovetova MG; Maianskaia SD; Torim IuIu; Karpov RS
    Kardiologiia; 2013; 53(3):9-14. PubMed ID: 23548421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
    Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
    J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
    Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of Gly389Arg beta1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol].
    Tepliakov AT; Shilov SN; Berezikova EN; Torim IuIu; Efremov AV; Safronov ID; Maianskaia SD; Popova AA; Voronina EN; Karpov RS
    Ter Arkh; 2010; 82(12):22-8. PubMed ID: 21516734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ACE gene polymorphism and ischemic chronic heart failure in Turkish population.
    Akbulut T; Bilsel T; Terzi S; Ciloglu F; Unal Dayi S; Sayar N; Peker I; Yesilcimen K
    Eur J Med Res; 2003 Jun; 8(6):247-53. PubMed ID: 12911874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.
    Contini M; Compagnino E; Cattadori G; Magrì D; Camera M; Apostolo A; Farina S; Palermo P; Gertow K; Tremoli E; Fiorentini C; Agostoni P
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):159-68. PubMed ID: 26847573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
    Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients.
    Huang W; Xie C; Zhou H; Yang T; Sun M
    Eur J Heart Fail; 2004 Jan; 6(1):23-7. PubMed ID: 15012915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-inhibitor therapy at relatively high doses and risk of renal worsening in chronic heart failure.
    De Vecchis R; Di Biase G; Ariano C; Cioppa C; Giasi A; Ciccarelli A; Pucciarelli A; Cantatrione S
    Arq Bras Cardiol; 2011 Dec; 97(6):507-16. PubMed ID: 22001954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
    Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
    J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
    Skvortsov AA; Mareev VY; Chelmakina SM; Baklanova NA; Belenkov IuN
    Kardiologiia; 2007; 47(10):12-23. PubMed ID: 18260939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response to resistance training in CHF according to ACE genotype.
    Williams AD; Anderson MJ; Selig S; Carey MF; Febbraio MA; Hayes A; Toia D; Harrap SB; Hare DL
    Int J Cardiol; 2011 Jun; 149(3):330-4. PubMed ID: 20189663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.